G. Michael Landis insider trades
Open-market stock purchases and sales by G. Michael Landis, Chief Financial Officer at Polaryx Therapeutics, Inc, from SEC Form 4 filings since Oct 26, 2012.
Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -12%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Feb 18, 2026 | PLYX Polaryx Therapeutics, Inc | Bought | $8K |